Here's a Quick Look Into the Fundamentals of Walgreens Boots Alliance (WBA) Stock

Large-cap consumer staples company Walgreens Boots Alliance has moved -1.3% this overnight, reaching $20.51 per share. In contrast, the average analyst target price for the stock is $27.54.

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. The company is based in the United States. Walgreens Boots Alliance currently returns an annual dividend yield of 9.2%.

What to Consider if You Are Thinking of Buying Walgreens Boots Alliance:

  • Walgreens Boots Alliance has moved -49.0% over the last year.

  • WBA has a forward P/E ratio of 5.6 based on its EPS guidance of 3.67.

  • Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of -18.5%.

  • The company has a price to earnings growth (PEG) ratio of -0.75.

  • Its Price to Book (P/B) ratio is 0.88

Walgreens Boots Alliance Has None

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 2,258,000 2,117,000 141,000 -93.49
2022 3,899,000 1,734,000 2,165,000 -48.16
2021 5,555,000 1,379,000 4,176,000 1.61
2020 5,484,000 1,374,000 4,110,000 5.6
2019 5,594,000 1,702,000 3,892,000 -43.56
2018 8,263,000 1,367,000 6,896,000


The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.